Virax Biolabs Group annual operating expenses
2021
2022
2023
2024
2025
2026
Virax Biolabs Group Operating Expenses Growth & History (VRAX)
Virax Biolabs Group's operating expenses was $6.4M for fiscal 2026.
View full Virax Biolabs Group company overviewVirax Biolabs Group annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $6.4M | $297,590 | +4.87% |
| 2025 | 2025-03-31 | $6.1M | −$437,233 | −6.68% |
| 2024 | 2024-03-31 | $6.5M | $815,667 | +14.23% |
| 2023 | 2023-03-31 | $5.7M | $4.0M | +230.59% |
| 2022 | 2022-03-31 | $1.7M | $1.1M | +172.98% |
| 2021 | 2021-03-31 | $635,104 | — | — |
Virax Biolabs Group operating expenses trends
Over the last five fiscal years, Virax Biolabs Group's operating expenses increased from $635,104 to $6.4M, a change of $5.8M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Virax Biolabs Group source filings ↗